Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-7.04	36.90	39.69
Graham Fair Price	14.22	1071.45	938.06
PEG	-96.37	0.49	13.63
Price/Book	5.53	0.86	0.81
Price/Cash Flow	-81.98	19.10	-106.01
Prices/Earnings	-24.85	17.49	23.27
Price/Sales	-4.11	3.64	3.80
Price/FCF	-81.98	19.10	-106.01
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	16.97	0.20	0.17
Operating Margin	19.03	0.11	0.09
ROA	34.52	< 0.005	< 0.005
ROE	< 0.005	0.01	40.42
ROIC	< 0.005	< 0.005	31.75
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.03	< 0.005	206.86
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-0.08	0.26	234.34
EPS QOQ	0.02	0.35	1971.10
FCF QOQ	-17.05	6.65	-61.02
Revenue QOQ	-0.02	0.06	187.16
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.65	0.00	inf
Days Sales Outstanding (DSO)	11.19	9.95	-11.08
Inventory Turnover	139.03	0.00	inf
Debt/Capitalization	0.63	0.61	-4.01
Quick Ratio	0.40	0.51	26.63
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2116.94	2040.50	-3.61
Cash	471.42	570.91	21.10
Capex	-133.68	-103.00	22.95
Free Cash Flow	-16.22	91.58	464.59
Revenue	452.86	480.36	6.07
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.58	0.73	24.68
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	26.01	24.05	-7.53
Naive Interpretation	Member

06 - Financial Health · Bad

Rating